214 related articles for article (PubMed ID: 30582658)
61. Genetics for the diagnosis and treatment of mesenchymal tumors.
Lasota J; Fanburg-Smith JC
Semin Musculoskelet Radiol; 2007 Sep; 11(3):215-30. PubMed ID: 18260032
[TBL] [Abstract][Full Text] [Related]
62. BONE TUMOURS AND THEIR ENZYMES. A STUDY OF THE PHOSPHATASES, NON-SPECIFIC ESTERASES AND BETA-GLUCURONIDASE OF OSTEOGENIC AND CARTILAGINOUS TUMOURS, FIBROBLASTIC AND GIANT-CELL LESIONS.
JEFFREE GM; PRICE CH
J Bone Joint Surg Br; 1965 Feb; 47():120-36. PubMed ID: 14296235
[No Abstract] [Full Text] [Related]
63. Primary epithelioid sarcoma of bone: report of a unique case, with immunohistochemical and fluorescent in situ hybridization confirmation of INI1 deletion.
Raoux D; Péoc'h M; Pedeutour F; Vaunois B; Decouvelaere AV; Folpe AL
Am J Surg Pathol; 2009 Jun; 33(6):954-8. PubMed ID: 19342946
[TBL] [Abstract][Full Text] [Related]
64. Molecular Pathology of Bone Tumors: What Have We Learned and How Does It Affect Daily Practice?
Bovée JVMG
Surg Pathol Clin; 2017 Sep; 10(3):xiii-xiv. PubMed ID: 28797513
[No Abstract] [Full Text] [Related]
65. Chondroblastoma-like osteosarcoma: a clinicopathological and molecular study of a rare osteosarcoma variant.
Gaeta R; Righi A; Gambarotti M; Aretini P; Lessi F; Mazzanti CM; Mancini I; Pinzani P; Belgio B; Sbaraglia M; Tos APD; Franchi A
Histopathology; 2022 Sep; 81(3):389-401. PubMed ID: 35791778
[TBL] [Abstract][Full Text] [Related]
66. A novel next generation sequencing approach to improve sarcoma diagnosis.
McConnell L; Houghton O; Stewart P; Gazdova J; Srivastava S; Kim C; Catherwood M; Strobl A; Flanagan AM; Oniscu A; Kroeze LI; Groenen P; Taniere P; Salto-Tellez M; Gonzalez D
Mod Pathol; 2020 Jul; 33(7):1350-1359. PubMed ID: 32047232
[TBL] [Abstract][Full Text] [Related]
67. Clear cell tumors of bone.
Swanson PE
Semin Diagn Pathol; 1997 Nov; 14(4):281-91. PubMed ID: 9383827
[TBL] [Abstract][Full Text] [Related]
68. [DNA sequencing of H3F3A mutations in H3.3 immunohistochemistry-negative giant cell tumors of bone].
Gong LH; Zhang W; Sun XQ; Zhang M; Ding Y
Zhonghua Bing Li Xue Za Zhi; 2021 Mar; 50(3):190-193. PubMed ID: 33677880
[No Abstract] [Full Text] [Related]
69. [Significance of SATB2 in the pathologic diagnosis of osteosarcoma].
Li M; Cai YP; Lu KY; Chen Y; Zhu X; Yin Y; Tang J
Zhonghua Bing Li Xue Za Zhi; 2016 Sep; 45(9):631-5. PubMed ID: 27646893
[TBL] [Abstract][Full Text] [Related]
70. Pancreatic involvement by mesenchymal chondrosarcoma harboring the HEY1-NCOA2 gene fusion.
Cohen JN; Solomon DA; Horvai AE; Kakar S
Hum Pathol; 2016 Dec; 58():35-40. PubMed ID: 27544802
[TBL] [Abstract][Full Text] [Related]
71. The long tail of molecular alterations in non-small cell lung cancer: a single-institution experience of next-generation sequencing in clinical molecular diagnostics.
Fumagalli C; Vacirca D; Rappa A; Passaro A; Guarize J; Rafaniello Raviele P; de Marinis F; Spaggiari L; Casadio C; Viale G; Barberis M; Guerini-Rocco E
J Clin Pathol; 2018 Sep; 71(9):767-773. PubMed ID: 29535211
[TBL] [Abstract][Full Text] [Related]
72. [Lung cancer molecular testing, what role for Next Generation Sequencing and circulating tumor DNA].
Pécuchet N; Legras A; Laurent-Puig P; Blons H
Ann Pathol; 2016 Jan; 36(1):80-93. PubMed ID: 26803564
[TBL] [Abstract][Full Text] [Related]
73. Development and clinical validation of a circulating tumor DNA test for the identification of clinically actionable mutations in nonsmall cell lung cancer.
Liu L; Liu H; Shao D; Liu Z; Wang J; Deng Q; Tang H; Yang H; Zhang Y; Qiu Y; Cui F; Tan M; Zhang P; Li Z; Liu J; Liang W; Wang Y; Peng Z; Wang J; Yang H; Mao M; Kristiansen K; Ye M; He J
Genes Chromosomes Cancer; 2018 Apr; 57(4):211-220. PubMed ID: 29277949
[TBL] [Abstract][Full Text] [Related]
74. Osteosarcoma: Old and New Challenges.
Yoshida A
Surg Pathol Clin; 2021 Dec; 14(4):567-583. PubMed ID: 34742481
[TBL] [Abstract][Full Text] [Related]
75. [Primary bone and joint tumor--statistical analysis of 571 cases].
Yang DZ; Wu X
Zhonghua Zhong Liu Za Zhi; 1986 Jan; 8(1):51-4. PubMed ID: 3015534
[TBL] [Abstract][Full Text] [Related]
76. Novel treatment targets in sarcoma: more than just the GIST.
Shoushtari AN; Van Tine BA; Schwartz GK
Am Soc Clin Oncol Educ Book; 2014; ():e488-95. PubMed ID: 24857144
[TBL] [Abstract][Full Text] [Related]
77. Massive parallel sequencing in sarcoma pathobiology: state of the art and perspectives.
Brenca M; Maestro R
Expert Rev Anticancer Ther; 2015; 15(12):1473-88. PubMed ID: 26536249
[TBL] [Abstract][Full Text] [Related]
78. Mesenchymal chondrosarcoma diagnosed on FISH for HEY1-NCOA2 fusion gene.
Moriya K; Katayama S; Onuma M; Rikiishi T; Hosaka M; Watanabe M; Hasegawa T; Sasahara Y; Kure S
Pediatr Int; 2014 Oct; 56(5):e55-7. PubMed ID: 25336010
[TBL] [Abstract][Full Text] [Related]
79. BENIGN OSTEOBLASTOMA (GIANT OSTEOID OSTEOMA): REPORT OF AN UNUSUAL RIB TUMOUR AND REVIEW OF THE LITERATURE.
ROSENSWEIG J; PINTAR K; MIKAIL M; MAYMAN A
Can Med Assoc J; 1963 Dec; 89(23):1189-92. PubMed ID: 14091906
[No Abstract] [Full Text] [Related]
80. [Genetic instability in osteoblastic tumors of the skeletal system].
Roessner A; Radig K; Schneider-Stock R; Mittler U; Neumann HW
Verh Dtsch Ges Pathol; 1998; 82():133-43. PubMed ID: 10095425
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
